Guide
Canada Natural Health Products Readiness: NNHPD Licensing, NPN, Site Licence and Part 3 GMP
Canada regulates dietary supplements as Natural Health Products (NHPs) under the Natural Health Products Regulations (NHPR, SOR/2003-196), administered by the Natural and Non-prescription Health Products Directorate (NNHPD) inside Health Canada. Every NHP sold in Canada needs a Product Licence with an eight-digit Natural Product Number (NPN) or Homeopathic Medicine Number (DIN-HM) printed on the label, and every site that manufactures, packages, labels or imports an NHP needs a Site Licence. On top of licensing, Part 3 of the NHPR carries a full GMP code: premises, equipment, personnel, sanitation, operations, quality assurance, stability, records and sterility where applicable. This guide maps the three NNHPD gates a brand-owner has to clear, and how the 2022–2025 Self-Care Framework changes the labelling and cost-recovery posture.
Start free trial Free trial, no credit card, onboard in days, not months.
Product Licence and the NPN — the eight-digit number that gates every shipment
Under sections 4–7 of the NHPR, a Product Licence must be issued before an NHP is sold in Canada. The application goes through NNHPD's Compendial, Traditional or Non-traditional pathway depending on whether the formulation matches a Monograph, a Traditional Use claim, or requires full evidence. Compendial Class I (matches a monograph exactly) typically clears in 60 days; Class III non-traditional applications can take 210 days or longer. Once issued, the licence carries a Natural Product Number (NPN) — eight digits, mandatory on the principal display panel, and the single artefact a CBSA officer checks at the border. Without an NPN on the label, the shipment is refused or seized.
Site Licence — the second gate, with Quality Assurance Report on top
Sections 27–43 of the NHPR require every Canadian site that manufactures, packages, labels or imports an NHP to hold a Site Licence. An importer cannot bring product into Canada without a Site Licence even if the foreign manufacturer is the licensed producer. The application requires the company name and address, the activities to be performed, the dosage forms handled, and a Quality Assurance Report (QAR) signed by a qualified QA person describing the GMP system. The Site Licence is renewed annually; QAR updates must reflect any change in scope, dosage form or quality system. Site Licence holders appear on Health Canada's public Licensed Site database — buyers and partners check it.
Part 3 GMP — the nine subject areas inspectors actually walk
Part 3 of the NHPR is the GMP code. The nine areas are: premises (45), equipment (46), personnel (47), sanitation (48), operations (49), quality assurance (50), stability (51), records (52), and sterile products (53). Inspector walk-throughs follow the Health Canada Good Manufacturing Practices Guide (GUI-0048). The hot zones in recent inspections cluster on: stability data not supporting the labelled expiry (51), in-process testing missing for finished-product specifications (50), batch record gaps or missing two-person verification (52), and supplier qualification thin (49). For sterile NHPs, section 53 imports the equivalent of Annex 1 controls — environmental monitoring, media fills, container closure integrity.
Self-Care Framework, cost recovery and the labelling refresh
The Self-Care Framework consultation (2016–2018), the resulting Vanessa's Law amendments (2019) and the cost-recovery regulations (in force 1 April 2025) reshape the regulatory posture. Three concrete consequences. (1) Labelling — Plain Language Labelling for NHPs (SOR/2022-146) requires a Canadian Product Facts Table on consumer NHPs by transition dates running through 2028 (Class A allergens, three years from coming-into-force; ordinary NHPs, six years). (2) Cost recovery — annual licence fees for Product Licences and Site Licences moved from nominal to material; small business mitigation applies but must be claimed. (3) Vigilance — mandatory adverse drug reaction reporting under the Food and Drugs Act applies to NHPs through the equivalent NHP vigilance regime; an NHP serious AR must be reported to Health Canada Canada Vigilance.
A 150-day Canadian readiness path
Days 1–15: portfolio mapping — which SKUs run Compendial vs Traditional vs Non-traditional, which sites need Site Licences, what activities each site declares. Days 16–45: Product Licence applications — monograph match where possible, evidence assembly where not. Days 46–80: Site Licence application or amendment with QAR. Days 81–110: Part 3 GMP gap close — stability, in-process testing, supplier qualification, batch record completeness. Days 111–130: Plain Language Labelling refresh and Canadian Product Facts Table generation. Days 131–145: mock NNHPD inspection against GUI-0048. Days 146–150: Canada Vigilance setup and contact registration.
Standards covered in this guide
Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.
Where this lives in V5 Ultimate
The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.
Modules that do the work
Industries this hits hardest
Frequently asked
Is a US dietary supplement the same as a Canadian NHP?
No. A US supplement is a food under FDCA/DSHEA. A Canadian NHP is a sub-class of drug under the Food and Drugs Act with its own Part 3 GMP code and a mandatory pre-market licence (NPN). A US-marketed supplement cannot be sold in Canada without a Product Licence and a Canadian-licensed site or licensed importer.
How long does NPN issuance take?
A Compendial Class I application that matches an NNHPD monograph exactly is typically issued in 60 days. Class II (traditional with monograph reference) takes 90 days. Class III non-traditional with full evidence can take 210 days or more. The clock pauses during NNHPD information requests.
Does a foreign manufacturer need a Canadian Site Licence?
Foreign sites are not licensed directly. The Canadian importer of record must hold a Site Licence covering the import activity, and the foreign site's GMP evidence is reviewed as part of the importer's QAR. The label still needs the Canadian licence holder.
When does Plain Language Labelling apply to NHPs?
SOR/2022-146 phases the Canadian Product Facts Table in by NHP class — three years from coming-into-force for products containing recognised allergens, six years for ordinary NHPs. Brands selling into Canada should treat the label refresh as a 2025–2028 programme, not a 2028 sprint.
See it on your shop floor.
Free trial, no credit card, onboard in days, not months.
Related reading
- 10 CFR 35 medical use readiness — NRC licensing for radiopharmaceuticals
- 21 CFR 111 Readiness: Dietary Supplement cGMP Subparts E & F
- 21 CFR 211 Drug cGMP Readiness Guide
- 21 CFR 212 PET drug cGMP readiness — FDA inspection playbook
- 21 CFR 589 BSE / Ruminant Feed Ban Readiness Guide
- 21 CFR 820 to ISO 13485 Mapping Guide (Including QMSR Harmonisation)
Spot something off? .